80 related articles for article (PubMed ID: 11106265)
1. Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells.
Arafat WO; Casado E; Wang M; Alvarez RD; Siegal GP; Glorioso JC; Curiel DT; Gómez-Navarro J
Clin Cancer Res; 2000 Nov; 6(11):4442-8. PubMed ID: 11106265
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell vehicles for delivery of cytotoxic genes as a gene therapy approach for carcinoma of the ovary.
Rancourt C; Robertson MW; Wang M; Goldman CK; Kelly JF; Alvarez RD; Siegal GP; Curiel DT
Clin Cancer Res; 1998 Feb; 4(2):265-70. PubMed ID: 9516909
[TBL] [Abstract][Full Text] [Related]
3. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
Rancourt C; Bergeron C; Lane D; Garon G; Piché A
Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047
[TBL] [Abstract][Full Text] [Related]
4. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
[TBL] [Abstract][Full Text] [Related]
5. Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model.
Gómez-Navarro J; Contreras JL; Arafat W; Jiang XL; Krisky D; Oligino T; Marconi P; Hubbard B; Glorioso JC; Curiel DT; Thomas JM
Gene Ther; 2000 Jan; 7(1):43-52. PubMed ID: 10680015
[TBL] [Abstract][Full Text] [Related]
6. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.
Li S; Tokuyama T; Yamamoto J; Koide M; Yokota N; Namba H
Cancer Gene Ther; 2005 Jul; 12(7):600-7. PubMed ID: 15775995
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
Guan J; Ma L; Wei L
Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
[TBL] [Abstract][Full Text] [Related]
8. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
[TBL] [Abstract][Full Text] [Related]
9. [Antiglioma activity of endothelial progenitor cells transduced with HSV-TK via inhibiting angiogenesis in vitro and in vivo].
Zhang JX; Zhao P; Li R; Shi L; Cheng ZH; You YP; Fu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):170-4. PubMed ID: 19350509
[TBL] [Abstract][Full Text] [Related]
10. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
11. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells.
Namba H; Iwadate Y; Kawamura K; Sakiyama S; Tagawa M
Cancer Gene Ther; 2001 Jun; 8(6):414-20. PubMed ID: 11498761
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors.
Ferrari N; Glod J; Lee J; Kobiler D; Fine HA
Gene Ther; 2003 Apr; 10(8):647-56. PubMed ID: 12692593
[TBL] [Abstract][Full Text] [Related]
14. [Experimental studies on the characteristics of suicide gene system HSV-tk/GCV and its effect on dendritic cells].
Wang X; Li L; Feng K; Bai L; Pei X
Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):628-31. PubMed ID: 11877036
[TBL] [Abstract][Full Text] [Related]
15. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
Pasanen T; Hakkarainen T; Timonen P; Parkkinen J; Tenhunen A; Loimas S; Wahlfors J
Int J Mol Med; 2003 Oct; 12(4):525-31. PubMed ID: 12964030
[TBL] [Abstract][Full Text] [Related]
16. Adherent cells generated during long-term culture of human umbilical cord blood CD34+ cells have characteristics of endothelial cells and beneficial effect on cord blood ex vivo expansion.
Yoo ES; Lee KE; Seo JW; Yoo EH; Lee MA; Im SA; Mun YC; Lee SN; Huh JW; Kim MJ; Jo DY; Ahn JY; Lee SM; Chung WS; Kim JH; Seong CM
Stem Cells; 2003; 21(2):228-35. PubMed ID: 12634419
[TBL] [Abstract][Full Text] [Related]
17. Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On.
Hu WX; Zeng ZJ; Luo SQ; Chen Q
Chin Med J (Engl); 2004 Mar; 117(3):434-9. PubMed ID: 15043787
[TBL] [Abstract][Full Text] [Related]
18. A herpesvirus saimiri-based gene therapy vector with potential for use in cancer immunotherapy.
Stevenson AJ; Frolova-Jones E; Hall KT; Kinsey SE; Markham AF; Whitehouse A; Meredith DM
Cancer Gene Ther; 2000 Jul; 7(7):1077-85. PubMed ID: 10917211
[TBL] [Abstract][Full Text] [Related]
19. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
de Bont ES; Guikema JE; Scherpen F; Meeuwsen T; Kamps WA; Vellenga E; Bos NA
Cancer Res; 2001 Oct; 61(20):7654-9. PubMed ID: 11606408
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells.
Konson A; Ben-Kasus T; Mahajna JA; Danon A; Rimon G; Agbaria R
Cancer Gene Ther; 2004 Dec; 11(12):830-40. PubMed ID: 15359292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
